A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.
- DOI
- 10.1016/s1470-2045(21)00522-2
- Published
- 2021 Nov
- Container
- The Lancet. Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1470-2045-21-00522-2,
title = {A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.},
author = {Bancroft EK and Page EC and Brook MN and Thomas S and Taylor N and Pope J and McHugh J and Jones AB and Karlsson Q and Merson S and Ong KR and Hoffman J and Huber C and Maehle L and Grindedal EM and Stormorken A and Evans DG and Rothwell J and Lalloo F and Brady AF and Bartlett M and Snape K and Hanson H and James P and McKinley J and Mascarenhas L and Syngal S and Ukaegbu C and Side L and Thomas T and Barwell J and Teixeira MR and Izatt L and Suri M and Macrae FA and Poplawski N and Chen-Shtoyerman R and Ahmed M and Musgrave H and Nicolai N and Greenhalgh L and Brewer C and Pachter N and Spigelman AD and Azzabi A and Helfand BT and Halliday D and Buys S and Ramon Y Cajal T and Donaldson A and Cooney KA and Harris M and McGrath J and Davidson R and Taylor A and Cooke P and Myhill K and Hogben M and Aaronson NK and Ardern-Jones A and Bangma CH and Castro E and Dearnaley D and Dias A and Dudderidge T and Eccles DM and Green K and Eyfjord J and Falconer A and Foster CS and Gronberg H and Hamdy FC and Johannsson O and Khoo V and Lilja H and Lindeman GJ and Lubinski J and Axcrona K and Mikropoulos C and Mitra AV and Moynihan C and Ni Raghallaigh H and Rennert G and Collier R and IMPACT Study Collaborators and Offman J and Kote-Jarai Z and Eeles RA},
year = {2021},
journal = {The Lancet. Oncology},
doi = {10.1016/s1470-2045(21)00522-2},
url = {https://doi.org/10.1016/s1470-2045(21)00522-2}
}RIS
TY - JOUR TI - A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study. AU - Bancroft EK AU - Page EC AU - Brook MN AU - Thomas S AU - Taylor N AU - Pope J AU - McHugh J AU - Jones AB AU - Karlsson Q AU - Merson S AU - Ong KR AU - Hoffman J AU - Huber C AU - Maehle L AU - Grindedal EM AU - Stormorken A AU - Evans DG AU - Rothwell J AU - Lalloo F AU - Brady AF AU - Bartlett M AU - Snape K AU - Hanson H AU - James P AU - McKinley J AU - Mascarenhas L AU - Syngal S AU - Ukaegbu C AU - Side L AU - Thomas T AU - Barwell J AU - Teixeira MR AU - Izatt L AU - Suri M AU - Macrae FA AU - Poplawski N AU - Chen-Shtoyerman R AU - Ahmed M AU - Musgrave H AU - Nicolai N AU - Greenhalgh L AU - Brewer C AU - Pachter N AU - Spigelman AD AU - Azzabi A AU - Helfand BT AU - Halliday D AU - Buys S AU - Ramon Y Cajal T AU - Donaldson A AU - Cooney KA AU - Harris M AU - McGrath J AU - Davidson R AU - Taylor A AU - Cooke P AU - Myhill K AU - Hogben M AU - Aaronson NK AU - Ardern-Jones A AU - Bangma CH AU - Castro E AU - Dearnaley D AU - Dias A AU - Dudderidge T AU - Eccles DM AU - Green K AU - Eyfjord J AU - Falconer A AU - Foster CS AU - Gronberg H AU - Hamdy FC AU - Johannsson O AU - Khoo V AU - Lilja H AU - Lindeman GJ AU - Lubinski J AU - Axcrona K AU - Mikropoulos C AU - Mitra AV AU - Moynihan C AU - Ni Raghallaigh H AU - Rennert G AU - Collier R AU - IMPACT Study Collaborators AU - Offman J AU - Kote-Jarai Z AU - Eeles RA PY - 2021 JO - The Lancet. Oncology DO - 10.1016/s1470-2045(21)00522-2 UR - https://doi.org/10.1016/s1470-2045(21)00522-2 ER -
APA
EK, B., EC, P., MN, B., S, T., N, T., J, P., J, M., AB, J., Q, K., S, M., KR, O., J, H., C, H., L, M., EM, G., A, S., DG, E., J, R., F, L., AF, B., M, B., K, S., H, H., P, J., J, M., L, M., S, S., C, U., L, S., T, T., J, B., MR, T., L, I., M, S., FA, M., N, P., R, C., M, A., H, M., N, N., L, G., C, B., N, P., AD, S., A, A., BT, H., D, H., S, B., T, R. Y. C., A, D., KA, C., M, H., J, M., R, D., A, T., P, C., K, M., M, H., NK, A., A, A., CH, B., E, C., D, D., A, D., T, D., DM, E., K, G., J, E., A, F., CS, F., H, G., FC, H., O, J., V, K., H, L., GJ, L., J, L., K, A., C, M., AV, M., C, M., H, N. R., G, R., R, C., Collaborators, I. S., J, O., Z, K., & RA, E. (2021). A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(21)00522-2
Source records
- pubmed · retrieved 2026-09-26T11:16:08.594Z